SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-018845
Filing Date
2024-01-30
Accepted
2024-01-30 09:00:30
Documents
15
Period of Report
2024-01-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d741606d8k.htm   iXBRL 8-K 27008
2 EX-99.1 d741606dex991.htm EX-99.1 10226
  Complete submission text file 0001193125-24-018845.txt   168767

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA maia-20240124.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20240124_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20240124_pre.xml EX-101.PRE 11707
16 EXTRACTED XBRL INSTANCE DOCUMENT d741606d8k_htm.xml XML 3744
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 24576016
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)